Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot International flag

This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions

Example Composition: Guideline: ADA 2021 Standards of Medical Care 8. Obesity Management for the Treatment of Type 2 Diabetes

Generated Narrative: Composition

Resource Composition "179465" Version "12" Updated "2023-12-05 14:12:24+0000"

Profile: Guideline

Artifact Description: Example of Guideline Profile of Composition Resource.

url: https://fevir.net/resources/Composition/179465

identifier: FEvIR Object Identifier: 179465

status: final

type: EvidenceReport (Evidence Based Medicine on FHIR Implementation Guide Code System#EvidenceReport)

category: Guideline (Evidence Based Medicine on FHIR Implementation Guide Code System#Guideline)

date: 2023-12-05 14:12:24+0000

author: : Brian S. Alper

title: Guideline: ADA 2021 Standards of Medical Care 8. Obesity Management for the Treatment of Type 2 Diabetes

custodian: Organization/118079: Computable Publishing LLC "Computable_Publishing_LLC"

RelatesTos

-TypeCitationResourceReference
*cite-asGuideline: ADA 2021 Standards of Medical Care 8. Obesity Management for the Treatment of Type 2 Diabetes [Composition]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179465. Revised 2023-11-23. Available at: https://fevir.net/resources/Composition/179465. Computable resource at: https://fevir.net/resources/Composition/179465.
*specification-of Citation/32137: JournalArticleCitation: ADA 2021 Standards of Medical Care 8. Obesity Management for the Treatment of Type 2 Diabetes